NYSE:BMYPharmaceuticals
How Bristol Myers Squibb’s Claude AI Deployment Across its Pipeline (BMY) Has Changed Its Investment Story
Earlier this month, Bristol Myers Squibb announced a wide-ranging partnership with Anthropic to deploy Claude AI across R&D, clinical development, manufacturing, commercial, and corporate functions to help accelerate drug development and operational workflows.
This move, combined with Bristol Myers Squibb’s separate AI-focused collaboration with Tempus AI on clinical trial design, signals a broad push to integrate advanced data and AI tools throughout the company’s development...